After a long pause, it looks as though the market for initial public offerings (IPOs) may be heating up again. Even amid ...

The UKHSA said that mosquito-borne infections like dengue can cause pain in the eyes and make them bleed, fever, severe ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of ...

GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway and clinical sites confirmed  Additional data evaluating GEO-CM04S1 as ...

Mihir Vora, CIO at Trust Mutual Fund, discusses market trends, highlighting the end of the correction phase and the potential ...

Presently tied up in Senate confirmation hearings, Mehmet Cengiz Oz, the Oprah Winfrey–certified wellness advocate known as ...

To participate in the call, please dial 833-816-1132 (Toll-Free/North America) or 412-317-0711 (International/Toll) and ask for the IMUNON Phase 3 protocol call. A live webcast of the call will also ...

Mogotes Metals Inc. is pleased to report on the start of ground based geophysical survey and further positive observations from ongoing reconnaissance of the recently optioned claims directly south of ...

Inflection Resources Ltd. is pleased to announce that AngloGold Ashanti Australia Limited has completed Phase I of the Exploration Earn-in Agreement announced on 14, 2023 by investing AUD$10,000,000 ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.